Functional measures, inflammatory markers and endothelin-1 as predictors of 360-day survival in centenarians

Age

Volumn 37, Issue 5, 2015, Pages

  Szewieczek, Jan ^a   Francuz, Tomasz ^a   Dulawa, Jan ^a   Legierska, Katarzyna ^a   Hornik, Beata ^a   Włodarczyk, Iwona ^a   Janusz Jenczeń, Magdalena ^a   Batko Szwaczka, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

360 day survival; Activities of daily living; Centenarians; Endothelin 1; Interleukin 6; Mini Mental State Examination

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ENDOTHELIN 1; INTERLEUKIN 6; MARKER; BIOLOGICAL MARKER;

AGED; ARTICLE; BARTHEL INDEX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FUNCTIONAL STATUS; HUMAN; INFLAMMATION; KATZ INDEX; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; LEUKOCYTE COUNT; MALE; MINI MENTAL STATE EXAMINATION; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; AGING; BLOOD; COGNITION; DAILY LIFE ACTIVITY; EPIDEMIOLOGY; GERIATRIC ASSESSMENT; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; POLAND; PROCEDURES; TRENDS;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; C-REACTIVE PROTEIN; COGNITION; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLAND; SURVIVAL RATE;

EID: 84939552588     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-015-9822-9     Document Type: Article

References (58)

1. Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT (2012) Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci 67:395–405
2. Arnold J, Dai J, Nahapetyan L, Arte A, Johnson MA, Hausman D, Rodgers WL, Hensley R, Martin P, Macdonald M, Davey A, Siegler IC, Jazwinski SM, Poon LW (2010) Predicting successful aging in a population-based sample of Georgia centenarians. Curr Gerontol Geriatr Res 2010:989315
3. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW, CAPTURE investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440–1445
4. Barodka VM, Joshi BL, Berkowitz DE, Hogue Jr CW, Nyhan D (2011) Review article: implications of vascular aging. Anesth Analg 112:1048–1060
5. Bizbiz L, Bonithon-Kopp C, Ducimetierè P, Berr C, Alperovitch A, Robert L (1996) Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherosclerosis 120:47–55
6. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104:1336–1342
7. Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166–2179
8. Blüher M, Fasshauer M, Tönjes A, Kratzsch J, Schön MR, Paschke R (2005) Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 113:534–537
9. Brunner F, Brás-Silva C, Cerdeira AS, Leite-Moreira AF (2006) Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 111(2):508–531
10. Bruunsgaard H, Andersen-Ranberg K, Hjelmborg JB, Pedersen BK, Jeune B (2003) Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am J Med 115:278–283
11. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M (2009) C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 151:483–495
12. Central Statistical Office of Poland (2014) Prognoza ludnosci na lata 2014-2050 (opracowana 2014 r.) http://stat.gov.pl/obszary-tematyczne/ludnosc/prognoza-ludnosci/prognoza-ludnosci-na-lata-2014-2050-opracowana-2014-r-,1,5.html. Accessed 28 March 2015
13. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108:2317–2322
14. Cesari M, Pahor M, Incalzi RA (2010) Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther 28:e72–e91
15. Cunningham C, Hennessy E (2015) Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers Res Ther 7:33
16. D’Erasmo E, Pisani D, Ragno A, Romagnoli S, Spagna G, Acca M (1997) Serum albumin level at admission: mortality and clinical outcome in geriatric patients. Am J Med Sci 314:17–20
17. Elisa T, Antonio P, Giuseppe P, Alessandro B, Giuseppe A, Federico C, Marzia D, Ruggero B, Giacomo M, Andrea O, Daniela R, Mariaelisa R, Claudio L (2015) Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis. J Immunol Res 2015:147616. doi:10.1155/2015/147616
18. Evert J, Lawler E, Bogan H, Perls T (2003) Morbidity profiles of centenarians: survivors, delayers and escapers. J Gerontol A Biol Sci Med Sci 58A:232–237
19. Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
20. Franceschi C, Bonafè M (2003) Centenarians as a model for healthy aging. Biochem Soc Trans 31:457–461
21. Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S4–S9
22. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
23. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128:92–105
24. Genc H, Dogru T, Tapan S, Tasci I, Bozoglu E, Gok M, Aslan F, Celebi G, Erdem G, Avcu F, Ural AU, Sonmez A (2012) Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome. Clin Biochem 45:92–95
25. Hansson J, Vasan RS, Ärnlöv J, Ingelsson E, Lind L, Larsson A, Michaëlsson K, Sundström J (2011) Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS One 6:e16185
26. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96:4219–4225
27. Inami N, Nomura S, Inami O, Kimura Y, Urase F, Maeda Y, Iwasaka T (2009) Significance of soluble CD40 ligand, adiponectin and reactive oxygen metabolites in aging. Arch Gerontol Geriatr 49:13–16
28. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919
29. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
30. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, Elkhalil L, Fruchart JC, Ducimetiere P, PRIME Study Group (2003) Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis 170:169–176
31. Maes M, DeVos N, Wauters A, Demedts P, Maurits VW, Neels H, Bosmans E, Altamura C, Lin A, Song C, Vandenbroucke M, Scharpe S (1999) Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer’s disease. J Psychiatr Res 33:397–405
32. Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:56–61
33. McMurtry CT, Rosenthal A (1995) Predictors of 2-year mortality among older male veterans on a geriatric rehabilitation unit. J Am Geriatr Soc 43:1123–1126
34. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M, Nourhashemi F (2013) Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14:877–882
35. Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL (2008) Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 29:1096–1102
36. Mossakowska M, Broczek K, Wieczorowska-Tobis K, Klich-Rączka A, Jonas M, Pawlik-Pachucka E, Safranow K, Kuznicki J, Puzianowska-Kuznicka M (2014) Cognitive performance and functional status are the major factors predicting survival of centenarians in Poland. J Gerontol A Biol Sci Med Sci 69:1269–1275
37. Olenchock BA, Wiviott SD, Murphy SA, Cannon CP, Rifai N, Braunwald E, Morrow DA (2008) Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J Thromb Thrombolysis 26:79–84
38. Park MH, Kwon DY, Jung JM, Han C, Jo I, Jo SA (2013) Mini-Mental Status Examination as predictors of mortality in the elderly. Acta Psychiatr Scand 127:298–304
39. Paulus P, Jennewein C, Zacharowski K (2011) Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 16:S11–S21
40. Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T (2003) Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 49:293–300
41. Santabárbara J, Lopez-Anton R, Marcos G, De-la-Cámara C, Lobo E, Saz P, Gracia-García P, Ventura T, Campayo A, Rodríguez-Mañas L, Olaya B, Haro JM, Salvador-Carulla L, Sartorius N, Lobo A (2014) Degree of cognitive impairment and mortality: a 17-year follow-up in a community study. Epidemiol Psychiatr Sci Available on CJO. doi:10.1017/S2045796014000390 1-9
42. Sebastiani P, Sun FX, Andersen SL, Lee JH, Wojczynski MK, Sanders JL, Yashin A, Newman AB, Perls TT (2013) Families Enriched for Exceptional Longevity also have Increased Health-Span: Findings from the Long Life Family Study. Front Public Health 1:38
43. Selvais PL, Robert A, Ahn S, van Linden F, Ketelslegers JM, Pouleur H, Rousseau MF (2000) Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 6:201–207
44. Skalska AB, Pietrzycka A, Stepniewski M (2009) Correlation of endothelin-1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem 42:358–364
45. Sun Z (2015) Aging, arterial stiffness, and hypertension. Hypertension 65:252–256
46. Szewieczek J, Dulawa J, Gminski J, Kurek A, Legierska K, Francuz T, Włodarczyk-Sporek I, Janusz-Jenczen M, Hornik B (2011) Better cognitive and physical performance is associated with higher blood pressure in centenarians. J Nutr Health Aging 15:618–622
47. Szewieczek J, Dulawa J, Francuz T, Legierska K, Hornik B, Włodarczyk-Sporek I, Janusz-Jenczeń M, Batko-Szwaczka A (2015) Mildly elevated blood pressure is a marker for better health status in Polish centenarians. Age 37:1–9
48. Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68:1902–1908
49. Terry DF, Sebastiani P, Andersen SL, Perls TT (2008) Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 168:277–283
50. Thakore AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D’Agostino Sr RB, Lipinska I, Keaney Jr JF, Benjamin EJ, O’Donnell CJ (2007) Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 99:1598–1602
51. Tousoulis D, Androulakis E, Papageorgiou N, Briasoulis A, Siasos G, Antoniades C, Stefanadis C (2010) From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand. Trends Cardiovasc Med 20:153–164
52. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH (1997) Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17:1121–1127
53. Van Beneden R, Gurné O, Selvais PL, Ahn SA, Robert AR, Ketelslegers JM, Pouleur HG, Rousseau MF (2004) Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study. J Card Fail 10:490–495
54. Wichmann MA, Cruickshanks KJ, Carlsson CM, Chappell R, Fischer ME, Klein BE, Klein R, Tsai MY, Schubert CR (2014) Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc 62:1683–1691
55. Willcox DC, Willcox BJ, Poon LW (2010) Centenarian studies: important contributors to our understanding of the aging process and longevity. Curr Gerontol Geriatr Res 2010:484529
56. Wojakowski W, Gminski J (2001) Soluble ICAM-1, VCAM-1 and E-selectin in children from families with high risk of atherosclerosis. Int J Mol Med 7:181–185
57. Yuan M, Ohishi M, Wang L, Raguki H, Wang H, Tao L, Ren J (2010) Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients. Clin Exp Pharmacol Physiol 37:848–851
58. Zakynthinos E, Pappa N (2009) Inflammatory biomarkers in coronary artery disease. J Cardiol 53:317–333